Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,600,693 shares of RVMD stock, worth $60.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,600,693
Previous 1,930,468
17.08%
Holding current value
$60.8 Million
Previous $68.3 Million
13.73%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding RVMD
# of Institutions
331Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$598 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$544 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$509 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$402 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$390 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.33B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...